Cracking the Biotech Code

Genzyme CSO Alan Smith discovered the initiation codon and mapped out SV40, then started himself on a career in biotech.

Written byKeith O'Brien
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Alan Smith grew up in southern England thinking he wanted to go into astronomy. But once at Christ's College in Cambridge, Smith realized that the required physics courses bored him. He switched his focus to biochemistry, a rapidly evolving field, and earned his bachelor's degree in 1967. He then set out to earn his PhD at the prestigious MRC Laboratory of Molecular Biology (LMB).

"The structure of DNA had only been known for 12 years at that point," recalls Smith, now 61 and chief scientific officer at Cambridge, Mass.-based Genzyme. "Protein synthesis - how it happened - was only beginning to be sorted out. And the people who were doing it were right there."

Smith says he was more than a little star-struck to find himself at the LMB, at a place that "to this day, has won more Nobel prizes than any other square footage of the planet." Despite ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies